Thalassemia Patients and Friends

Discussion Forums => Iron Chelation Corner => Topic started by: Narendra on April 02, 2007, 06:33:23 PM

Title: New Oral Chelator in Clinical Trial by Genzyme
Post by: Narendra on April 02, 2007, 06:33:23 PM

Hello Group,

I was at the TAG Conference this weekend in Boston and there were few representatives from Genzyme who mentioned they are working on a new oral chelator. I did get a chance to talk with them and they mentioned they have this product under clinical trail. Below is the information I could find out from the Genzyme site

http://www.genzymeclinicalresearch.com/trials/output/conditions/gzcr_res_BetaThal/cr_p_GTC-134-102.asp#TopOfPage (http://www.genzymeclinicalresearch.com/trials/output/conditions/gzcr_res_BetaThal/cr_p_GTC-134-102.asp#TopOfPage)

Title: Re: New Oral Chelator in Clinical Trial by Genzyme
Post by: §ãJ¡Ð ساجد on April 03, 2007, 05:59:45 AM

This is quite exciting!

Another option for chelation is definitely a good news for us. Now Novartis is going to face serious competition with L1 and deferitrin (GT56-252), which means reduced prices of Desferal and Exjade :yay

I can't wait till they release the results. I sure hope they will be good enough.

Take care, Peace!